Class of 2023
Scientific Area of Expertise: Cancer Drug Development, Early Phase Clinical Trials, Patient Life Quality
For unrivaled clinical cancer research contributions including expertly and extensively designing and executing innovative early-phase clinical trials; and for improving therapeutic outcomes to not only reduce mortality rates, but also enhance the quality of life for patients with cancer.